Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026)
Boston Scientific (BSX) posted quarterly Other Non-Current Assets of $45.2 billion for Q2 2026, up 8.8% year-over-year from $41.6 billion in Q2 2025, and up 1.95% on a QoQ basis from $44.4 billion in Q1 2026.
Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Boston Scientific has reported Other Non-Current Assets for 18 years, with the latest figure at $45.2 billion in Q2 2026.
- Other Non-Current Assets for Q2 2026 came in at $45.2 billion, up 8.8% year-over-year; the trailing twelve-month figure through Jun 2026 was $45.2 billion (up 8.8% YoY), and the FY2025 annual result was $43.7 billion, up 10.86% from the prior year.
- Other Non-Current Assets advanced to $45.2 billion in Q2 2026, from $44.4 billion in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $45.2 billion in Q2 2026 and troughed at $1.4 billion in Q1 2022.
- A 5-year average of $21.0 billion and a median of $17.1 billion in 2022 frame the typical range for Other Non-Current Assets.
- The widest annual swing landed in 2022, when Other Non-Current Assets declined 19.78%; it then surged 2579.5% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $32.5 billion in 2022, then advanced by 8.21% to $35.1 billion in 2023, then increased by 12.12% to $39.4 billion in 2024, then increased by 10.86% to $43.7 billion in 2025, then climbed by 3.53% to $45.2 billion in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $45.2 billion in Q2 2026, $44.4 billion in Q1 2026, and $43.7 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.23 Bn | 18.82 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.22 Bn |
| Mar 31, 2026 | 2.05 Bn |
| Dec 31, 2025 | 43.67 Bn |
| Sep 30, 2025 | 42.71 Bn |
| Jun 30, 2025 | 41.56 Bn |
| Mar 31, 2025 | 40.14 Bn |
| Dec 31, 2024 | 39.40 Bn |
| Sep 30, 2024 | 1.64 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Dec 31, 2023 | 35.14 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.60 Bn |
| Mar 31, 2023 | 1.48 Bn |
| Dec 31, 2022 | 1.50 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.44 Bn |